http://www.lse.co.uk/regulatory-news-article.asp?ArticleCode=ylykrol9&ArticleHeadline=Stroke__Brain_Injury_Clinical_Trial_in_Australia
RNS Number : 2344N
Rex Bionics PLC
24 October 2016
�
�
Rex Bionics Plc
("Rex Bionics" or the "Company")
�
�
REX Stroke and Brain Injury Clinical Trial in Australia
�
24 October 2016:�Rex Bionics Plc (AIM:
RXB), the pioneer of the REX Robot technology that enhances the mobility
of wheelchair users, is pleased to announce the start of a new clinical
trial treating patients who have had a stroke or brain injury, with
Robot-Assisted Physiotherapy with REX.�
�
The trial is being conducted by the
Australian Institute of Neuro-rehabilitation, Nelson Bay, New South
Wales (NSW), Australia and the University of Newcastle, NSW; and is
supported by The Newcastle Permanent Charitable Foundation and Rex
Bionics plc.� The trial has received ethics clearance through the Hunter
New England Human Research Ethics Committee (Ref: 16/08/17/4.06) and
will be carried out according to the standards of the National Health
and Medical Research Council of Australia.
�
The trial will recruit volunteers from
the Hunter Region of NSW, who have had a stroke or head injury more than
three months previously and have difficulty standing and walking.�
Volunteers will be treated twice a week for twelve weeks and the REX
treatment will be supplemented by a home programme of exercises.�� There
is provision for MRI examination to correlate the functional and
neurological response to treatment.�
�
More than one-third of people who survive
a stroke or head injury need help in walking and some will never regain
the ability to stand without assistance. This affects the patient's
ability to participate in rehabilitation, their long term health, and
the ability to do social, work and leisure activities.
There are more than 420,000 people living
with the effects of stroke in Australia and 30% of these people are of
working age.� 65% of those living with stroke also suffer a disability
that impedes their ability to carry out daily living activities
unassisted.� In 2012, the total financial costs of stroke in Australia
were estimated to be A$5 billion.
�
Trish Leonard, the Founder of AIN, commented:�"In
REX's self-supporting exoskeleton we see the potential to provide
greater opportunities for weight bearing exercises to people with stroke
and other acquired brain injuries. We are excited to be involved in
ground breaking research to evaluate REX's robotic exercise therapy as a
neuro-rehabilitation tool"
No comments:
Post a Comment